Market Analysis -The Emergence of Stem Cell Research & Therapy

Publication Date	March 2006
Publisher	Synergyst
Product Type	Report
Pages	85
ISBN Number	not applicable
Product Code	SYG03094

Price

£185.00
approximately: $346 | €235

PDF immediate delivery

PRINT £270 ($504 | €342)

CD-ROM £270 ($504 | €342)

Order above formats by FAX

Summary

Stem cell therapy is fast emerging as a potentially revolutionary new way to treat disease and injury, with wide-ranging medical benefits. With an aim to repair damaged and diseased body parts with healthy new cells provided by stem cell transplants, stem cell therapy has drawn both appreciation as well as a lot of negative publicity. Stem cell therapy offers many an opportunity to treat many degenerative diseases caused by the premature death or malfunction of specific cell types and the body's failure to replace or restore them. Synergyst's Market Analysis on The Emergence of Stem Cell Research & Therapy focuses on this highly controversial industry.

The report gives introductory information on stem cells, the history of stem cells, the various types of stem cells, sources from which stem cells are derived, why stem cells are important and why there is a fierce debate over their use, amongst others. The report also analyzes the various types of stem cell research available, and the know-hows of stem cell therapy, the benefits of stem cell research, potential therapies, how stem cell therapy can be used to treat diseases, etc.

A major section is dedicated to providing research on the various barriers facing this technology including moral, spiritual, and religious factors. The cost effectiveness of stem cell therapy and the availability of funding for stem cell research are also discussed in-depth in the report.

Perhaps the most important issue affecting this tremendously developing field is that of regulatory barriers. Synergyst's report explores the various US laws affecting this industry, along with a comparison of US versus internal laws on stem cell research. The disadvantages that the US is presently facing and is likely to continue to face in the near future in terms of regulatory barriers has also been focuses on and developed in a highly competitive manner in the report.

An analysis of the major players in the industry in the US, and a detailed future outlook completes this comprehensive intelligence guide to a rapidly developing industry which is faced by more challenges than perhaps any other industry globally today. Synergyst's Market Analysis on The Emergence of Stem Cell Research & Therapy is the perfect solution to the know-hows of this highly competitive industry.

Content

I. Executive Summary
II. Introduction To Stem Cells
- a. What are Stem Cells?
- b. History of Stem Cells
- c. Types of Stem Cells
  - I. Totipotent Stem Cells
  - II. Puripotent Stem Cells
  - III. Multipotent Stem Cells
- d. Deriving Stem Cells
- e. Importance of Stem Cells
- f. Debate over Stem Cell Research
- g. Stem Cell Research vs. Cloning
III. Stem Cell Research
- a. Embryonic Stem Cell Research
- b. Adult Stem Cell Research
IV. Stem Cell Therapy
- a. What is Stem Cell Therapy?
- b. Highlights of Stem Cell Therapy Research
- c. Benefits of Stem Cell Therapy
- d. Potential Stem Cell Therapies
  - I. Therapeutic Cloning
  - II. Generic Embryonic Stem Cell
  - III. Embryonic Stem Cell for Tissue Repair
  - IV. Adult Stem Cell Therapies
V. Treating Diseases With Stem Cells
- a. Limitation of Stem Cell Therapies by Immune Rejection
- b. Potential Applications of Mesenchymal Stem Cells
- c. Adult Stem Cells vs. Embryonic Stem Cells
- d. Possible Treatment for Diseases
  - I. Blood Disorders
  - II. Cancer
  - III. Diseases of Bone and Cartilage
  - IV. Nervous System Diseases
  - V. Primary Immunodeficiency Diseases
  - VI. Toxicity and Drug Testing
  - VII. Transplantable Organs
  - VIII. Type 1 Diabetes in Children
VI. Barriers To Stem Cell Development
- a. Spiritual and Religious Issues
- b. Ethical & Moral Issues
  - I. Issues Surrounding the Source of Stem Cells
  - II. Moral Issues with Human Stem Cells
  - III. Issues Surrounding the Destruction of the Embryo
  - IV. Issues Surrounding Cloning
- c. Economics of Stem Cells
- d. Justice Implications
- e. Oversight & Lack of Accountability
  - I. Public Sector Oversight
  - II. Private Sector Oversight
- f. Intellectual Property Rights
VII. Funding For Stem Cell Research
- a. Present US Law & Policy on Stem Cell Research
  - I. History of Embryo Research Funding
  - II. Current Federal Policy
  - III. Moral Issues Affecting the Policy
  - IV. Significance & Requirement of Federal Funding
  - V. Implementing the Current Policy
  - VI. Conclusion
VIII. Us Vs. International Law
- a. US Stance
- b. Australia
- c. Canada
- d. China
- e. Germany
- f. Israel
- g. Japan
- h. UK
- I. Singapore
- j. Others
- k. Technological & Economical Disadvantage for US
- l. Potential Loss of Ethical Oversight
- m. Disparities between State & Federal Laws
IX. International Reaction To Human Stem Cell Research
- a. Australia
- b. European Union
- c. United Kingdom
- d. United States
X. Major Players In The Us Market
- a. Aastrom Biosciences
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Portfolio
  - IV. R&D in Stem Cells
  - V. Recent Developments
- b. BioTransplant
  - I. Company Portrait
  - II. Financial Portrait
  - III. R&D in Stem Cells/Recent Developments
- c. Cryo-Cell International
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Portfolio
  - IV. R&D in Stem Cells/Recent Developments
- d. Geron
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Portfolio
  - IV. R&D in Stem Cells
  - V. Recent Developments
- e. StemCells
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Portfolio
  - IV. R&D in Stem Cells
  - V. Recent Developments
- f. Advanced Cell Technology Inc
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Portfolio
  - IV. R&D in Stem Cells
  - V. Recent Developments
- g. NeuroGeneration
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Profile
  - IV. R&D in Stem Cells/Recent Developments
- h. MultiCell Technologies
  - I. Company Portrait
  - II. Financial Portrait
  - III. Technology Portfolio/ R&D in Stem Cells
- V. Recent Developments
XI. Market Outlook For Stem Cell Research
Appendix And Glossary
List Of Figures And Tables
- Figure 1: Cell Cycle
- Figure 2: Development of the Pre-Implantation Blastocyst in Humans
- Figure 3: Development of Human Embryonic Tissues
- Figure 4: Major Goals in the Development of Transplantation Therapies from Human ES Cell Lines
- Figure 5: Genetic Manipulation of Human Embryonic Stem Cells
- Figure 6: Hematopoietic and Stromal Stem Cell Differentiation
- Figure 7: Development of Insulin-Secreting Pancreatic-Like Cells from Mouse Embryonic Stem Cells
- Table 1: Comparison of Mouse, Monkey & Human Pluripotent Stem Cells